Karolinska Development
An investment company that finances and supports innovative life science ventures.
KDEV | ST
Overview
Corporate Details
- ISIN(s):
- SE0002190850 (+1 more)
- LEI:
- 54930011ZA52NKO5W681
- Country:
- Sweden
- Address:
- Nanna Svartz väg 6A, 171 65 Solna
Description
Karolinska Development is an investment company specializing in the life sciences sector. It identifies, finances, and supports the creation and growth of companies developing innovative medical technologies and pharmaceuticals. The firm manages a diversified portfolio of biotechnology and medtech ventures, often originating from academic research, with the goal of developing ground-breaking treatments for severe diseases. Karolinska Development leverages its team's expertise in research, development, and commercialization to guide its portfolio companies, providing both capital and strategic support to advance innovations toward the market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2017-10-31 08:01 | English | 1.5 MB | |||
| 2017-10-27 19:10 |
Karolinska Development avyttrar sitt innehav i Xspray och erhåller 12,5 mkr dir…
|
Swedish | 501.2 KB | ||
| 2017-10-27 19:10 |
Karolinska Development divests its holdings in Xspray and receives SEK 12.5 mil…
|
English | 499.9 KB | ||
| 2017-10-16 08:01 |
The value of Karolinska Development's holdings in Umecrine Cognition increases …
|
English | 507.0 KB | ||
| 2017-10-16 08:01 |
Värdet av Karolinska Developments innehav i Umecrine Cognition ökar med SEK 196…
|
Swedish | 504.2 KB | ||
| 2017-10-12 08:01 |
Första handelsdag på Nasdaq Stockholm för Karolinska Developments portföljbolag…
|
Swedish | 499.5 KB | ||
| 2017-10-12 08:01 |
First day of trading in Karolinska Development's portfolio company BioArctic's …
|
English | 502.1 KB | ||
| 2017-10-04 08:01 |
Karolinska Development's portfolio company Umecrine Cognition secures financing…
|
English | 71.7 KB | ||
| 2017-10-04 08:01 |
Karolinska Developments portföljbolag Umecrine Cognition säkrar finansiering fö…
|
Swedish | 73.5 KB | ||
| 2017-09-13 08:01 |
Karolinska Development's portfolio company BioArctic intends to list on Nasdaq …
|
English | 505.3 KB | ||
| 2017-09-13 08:01 |
Karolinska Developments portföljbolag BioArctic avser genomföra notering på Nas…
|
Swedish | 504.1 KB | ||
| 2017-08-31 08:01 |
Ändring av antal aktier och röster i Karolinska Development
|
Swedish | 55.4 KB | ||
| 2017-08-31 08:01 |
Change of Number of Shares and Votes in Karolinska Development
|
English | 46.0 KB | ||
| 2017-08-29 18:00 | Swedish | 1.4 MB | |||
| 2017-08-29 18:00 | English | 1.5 MB |
Automate Your Workflow. Get a real-time feed of all Karolinska Development filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Karolinska Development
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Karolinska Development via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-04 | Johan Dighed | Other | Buy | 35,000 | 56,350.00 SEK |
| 2023-03-27 | Johan Dighed | Other | Buy | 50,000 | 89,000.00 SEK |
| 2023-02-17 | Hans Christopher Karl Osvald Perbandt Toll | Other | Buy | 35,000 | 72,100.00 SEK |
| 2022-12-19 | Johan Dighed | Other | Buy | 50,000 | 83,500.00 SEK |
| 2022-09-30 | Johan Dighed | Other | Buy | 40,187 | 72,336.60 SEK |
| 2020-06-26 | Hans Lennart Rudolf Wigzell | Other | Buy | 9,014 | 25,780.04 SEK |
| 2020-06-26 | Hans Lennart Rudolf Wigzell | Other | Buy | 5,000 | 14,350.00 SEK |
| 2020-06-24 | Hans Lennart Rudolf Wigzell | Other | Buy | 9,276 | 26,529.36 SEK |
| 2020-06-24 | Hans Lennart Rudolf Wigzell | Other | Buy | 4,645 | 13,331.15 SEK |
| 2020-06-23 | Hans Lennart Rudolf Wigzell | Other | Buy | 39,702 | 111,562.62 SEK |
Peer Companies
